title: The prognostic relevance of estimates of proliferative activity in early breast cancer.
authors.forename: M K
authors.initials: MK
authors.lastname: Heatley
authors.forename: P
authors.initials: P
authors.lastname: Maxwell
authors.forename: C
authors.initials: C
authors.lastname: Whiteside
authors.forename: P
authors.initials: P
authors.lastname: Ewing
authors.forename: P G
authors.initials: PG
authors.lastname: Toner
mesh_terms: D000911:Antibodies, Monoclonal / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000401:mortality* / Q000473:pathology / Q000503:physiopathology*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000378:metabolism / Q000401:mortality* / Q000473:pathology / Q000503:physiopathology*; D049109:Cell Proliferation; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D019394:Ki-67 Antigen / Q000032:analysis; D008198:Lymph Nodes / Q000473:pathology; D008940:Mitotic Index; D015999:Multivariate Analysis; D009367:Neoplasm Staging; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism; D015996:Survival Rate; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D019394:Ki-67 Antigen; D011960:Receptors, Estrogen